$AKRX News Speculators

New Post Public Reply Private Reply Replies (0) Message Board

Oct 7, 2014 at 10:14 AM

$AKRX News

Speculators live by the sword, die by the sword
3:13 p.m. July 8, 2014
- The Trading Deck

Dow, Nasdaq nail the breakout point
10:36 a.m. June 27, 2014
- Michael Ashbaugh

From tiny Akorns grow mighty oaks?
11:03 a.m. Nov. 21, 2013
- The Trading Deck

Rail-Splitter's top small-cap bets are worth watching
12:34 p.m. Nov. 4, 2013
- Insider Monkey

Akorn to buy Hi-Tech for $640 million in cash
8:02 a.m. Aug. 27, 2013
- MarketWatch.com

Monday’s biggest gaining and declining stocks
4:20 p.m. July 23, 2012
- MarketWatch

Corrective bounce, or sustainable upturn?
10:59 a.m. June 6, 2012
- Michael Ashbaugh

Charting a bearish double top
12:11 p.m. May 15, 2012
- Michael Ashbaugh

Charting a bearish double top
11:45 a.m. May 15, 2012
- Michael Ashbaugh

Wednesday’s biggest gaining and declining stocks
6:02 p.m. March 7, 2012
- Sue Chang

Tuesday’s biggest gaining and declining stocks
5:23 p.m. March 6, 2012
- MarketWatch

Stocks to watch Tuesday: Nutrisystem, Jakks
8:00 a.m. March 6, 2012
- MarketWatch

S&P 500 scratches out three-year high
12:07 p.m. March 2, 2012
- Michael Ashbaugh

Stocks to watch Friday: LinkedIn, LeapFrog, Nuance
7:46 a.m. Feb. 10, 2012
- MarketWatch

S&P 500 vies for positive 2011 finish
12:09 p.m. Dec. 23, 2011
- Michael Ashbaugh

S&P, Nasdaq retest major support
12:51 p.m. Dec. 12, 2011
- Michael Ashbaugh

U.S. markets survive test of major support
10:57 a.m. Nov. 2, 2011
- Michael Ashbaugh

Akorn rallies on earnings, M&A deal
1:59 p.m. Aug. 2, 2011
- Val Brickates Kennedy

Drug stocks slip; Emergent rallies
1:28 p.m. May 26, 2011
- Val Brickates Kennedy

Drug stocks gain; Derma, Elan climb
3:51 p.m. May 25, 2011
- Val Brickates Kennedy

Generics Firms Step Up Their Game In Branded Drugs

5:08 p.m. Oct. 6, 2014
- Investors Business Daily

Last patient completes treatment in Icon's Phase 3 for Verisome-based ocular therapy

10:44 a.m. Oct. 6, 2014
- Seeking Alpha

Medical Stocks Hang Tough As Market Falls

5:47 p.m. Oct. 3, 2014
- Investors Business Daily

Akorn buys rights to bronchodilator

6:36 p.m. Oct. 1, 2014
- Seeking Alpha

Akorn Upgraded On Strong Generic Drug Trends

11:09 a.m. Sept. 29, 2014
- Investors Business Daily

Meet 5 Top Stocks With Rising Earnings Estimates

7:02 a.m. Sept. 26, 2014
- Investors Business Daily

Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog

6:10 p.m. Sept. 23, 2014
- Zacks.com

Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog

4:55 p.m. Sept. 23, 2014
- Zacks.com

Acquisition-Hungry Akorn Sets Up Potential Buy Area

5:10 p.m. Sept. 22, 2014
- Investors Business Daily

Analysts Are Warming to These 5 Stocks

9:25 a.m. Sept. 22, 2014
- InvestorPlace.com

IBD 50: Akorn Aims For $1 Billion In Sales

5:35 p.m. Sept. 19, 2014
- Investors Business Daily

IBD 50 Stocks Setting Up, Including These 5 Medicals

5:35 p.m. Sept. 19, 2014
- Investors Business Daily

Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog

4:30 p.m. Sept. 18, 2014
- Zacks.com

Will Drugmaker Akorn Have A Healthy Bounce Up?

11:09 a.m. Sept. 18, 2014
- Investors Business Daily

Stocks with Upgraded Broker Ratings - Screen of the Week

3:57 a.m. Sept. 16, 2014
- Zacks.com

AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog

5:05 p.m. Sept. 12, 2014
- Zacks.com

5 Top Stocks With Rising Earnings Estimates

7:02 a.m. Sept. 12, 2014
- Investors Business Daily

Wall Street Breakfast: EU Places New Sanctions On Russia, U.S. To Follow

6:32 a.m. Sept. 12, 2014
- Seeking Alpha

Akorn In Second Test Of 10-Week Line

5:09 p.m. Sept. 11, 2014
- Investors Business Daily

Akorn reportedly eyeing tax inversion deal

4:07 p.m. Sept. 11, 2014
- Seeking Alpha

Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI)
Inhalation Solution (IS) to Akorn, Inc.
4:22 p.m. Sept. 30, 2014
- BusinessWire - BZX

Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion
4:16 p.m. Sept. 30, 2014
- GlobeNewswire

Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma
9:25 a.m. Sept. 8, 2014
- PR Newswire - PRF

Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn
8:30 a.m. Sept. 5, 2014
- PR Newswire - PRF

Akorn Completes Acquisition of VersaPharm
8:51 a.m. Aug. 12, 2014
- GlobeNewswire

Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed
9:20 a.m. Aug. 7, 2014
- PR Newswire - PRF

Akorn Reports Preliminary 2014 Second Quarter Results
6:05 a.m. Aug. 5, 2014
- GlobeNewswire

Global Parkinson%s Disease Market 2014-2018
6:42 p.m. July 28, 2014
- PR Newswire - PRF

Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information
11:34 a.m. July 15, 2014
- GlobeNewswire

Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt
6:50 a.m. July 2, 2014
- PR Newswire - PRF

Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics
6:40 a.m. June 27, 2014
- PR Newswire - PRF

Akorn Divests ECR Pharmaceuticals to Valeant
11:11 a.m. June 20, 2014
- BusinessWire - BZX

Aerie Pharmaceuticals Names Craig R. Skenes as Vice President,
Business Development
4:05 p.m. June 16, 2014
- BusinessWire - BZX

Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte
8:00 a.m. June 5, 2014
- PR Newswire - PRF

Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co.
7:20 a.m. May 16, 2014
- PR Newswire - PRF

Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn
11:30 a.m. May 9, 2014
- PR Newswire - PRF

Akorn to Acquire VersaPharm for $440 Million
9:19 a.m. May 9, 2014
- BusinessWire - BZX

Akorn Reports 2014 First Quarter Results
7:03 a.m. May 6, 2014
- BusinessWire - BZX

Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF

Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SES Sells to AFC Industries: A Strategic M&A Move

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Liberty Hill: 50 Years of Grassroots Revolution

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Mobile Iron IV Expansions: Targeting Texas Health Needs

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

Step Inside Henson's Creature Shop Magic in NYC

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Deadline Looms for EquipmentShare Investors' Legal Action

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

OneAscent Welcomes Monica Stoudemire as New CCO

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Merit Advisors Shines as Top Energy Workplace

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Veteran Marketer Joins The Wisory's Advisory Board

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....